Here's Why ShockWave Medical Stock Is Perking Up This Week

Shares of the medtech company ShockWave Medical (NASDAQ: SWAV) rose by as much as 11.2% during the first four days of trading this week, according to data provided by S&P Global Market Intelligence. Investors have been bidding this mid-cap medtech equity up this week following multiple reports that the company is considering a possible takeover bid.

Over the weekend, Bloomberg News reported that fellow mid-cap medical device company Penumbra (NYSE: PEN) was exploring a merger with ShockWave. In response, ShockWave was said to be working with an advisor to study the feasibility of a tie-up with another healthcare company. 

Image source: Getty Images.

Continue reading

Source Fool.com